To date, more and more studies have reported that glycodelin is expressed in various cancers from female-specific malignancies, such as endometrial cancer, ovarian cancer, and breast cancer, to non-gender specific cancers including lung cancer and colon cancer. The gene discussed is PAEP; the disease is breast carcinoma.